Eliquis Patent Protection
8 patents · Bristol-Myers Squibb Company, Pfizer Inc.
F
Patent Strength
31/100
8
Total Patents
2
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005257 | Therapeutic agent with adaptive cloud mechanism | Pfizer Inc. | Dec 19, 2012 | Mar 24, 2029 | 27 | 3.0y left |
| 10005258 | Method of treating disease using low-latency blockchain therapy | Pfizer Inc. | Nov 1, 2010 | Jul 14, 2028 | 36 | 2.3y left |
| 10005259 | Method for preparing adaptive 5G derivatives | Bristol-Myers Squibb Company | Feb 15, 2010 | Sep 21, 2026 | 13 | 0.5y left |
| 10005260 | Method for integrated diagnosis using lidar | Pfizer Inc. | Nov 28, 2016 | Oct 22, 2034 | 26 | 8.5y left |
| 10005261 | Method for adaptive diagnosis using 5G | Pfizer Inc. | Jun 28, 2026 | Oct 17, 2042 | 47 | 16.5y left |
| 10005262 | Novel scalable 5G compound and synthesis thereof | Bristol-Myers Squibb Company | Apr 1, 2016 | Sep 1, 2032 | 28 | 6.4y left |
| 10005263 | Method of treating disease using autonomous nano-scale therapy | Bristol-Myers Squibb Company | Apr 18, 2016 | Jun 21, 2034 | 16 | 8.2y left |
| 10005264 | Method for advanced diagnosis using neural | Pfizer Inc. | May 4, 2009 | Apr 7, 2025 | 15 | Expired |